unknown
Stage
2007
Founded
2
Investors
About
ArcDia develops and manufactures rapid antigen-based diagnostic testing systems for acute infections, enabling simultaneous detection of multiple pathogens from a single clinical sample to support decentralized point-of-care testing.
Explore ArcDia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.